CPMV

MOSAIC IMMUNOENGINEERING by Mosaic ImmunoEngineering Inc. (CPMV)

About MOSAIC IMMUNOENGINEERING by Mosaic ImmunoEngineering Inc. (CPMV)

Mosaic ImmunoEngineering, Inc. is a development-stage biotechnology company, which engages in the development of immunotherapies for the treatment of cancer. Its pipelines include human and veterinary immuno-oncology programs. The company was founded by Steven King, Paul Lytle, Nicole F. Steinmetz, Jonathan K. Pokorski, Steven N. Fiering, and Robert Garnick on August 21, 2020 and is headquartered in Huntington Beach, CA.

Details

Daily high
$0.78
Daily low
$0.78
Price at open
$0.78
52 Week High
$1.13
52 Week Low
$0.10
Market cap
5.6M
Dividend yield
0.00%
Volume
117
Avg. volume
274
P/E ratio
-6.04

MOSAIC IMMUNOENGINEERING by Mosaic ImmunoEngineering Inc. News

Details

Daily high
$0.78
Daily low
$0.78
Price at open
$0.78
52 Week High
$1.13
52 Week Low
$0.10
Market cap
5.6M
Dividend yield
0.00%
Volume
117
Avg. volume
274
P/E ratio
-6.04